Differential effects of the ApoE4 genotype on brain structure and function

NeuroImage

Volumn 89, Issue , 2014, Pages 81-91

  Matura, Silke ^a   Prvulovic, David ^a   Jurcoane, Alina ^a   Hartmann, Daniel ^a   Miller, Julia ^a   Scheibe, Monika ^a   O'Dwyer, Laurence ^a   Oertel Knöchel, Viola ^a   Knöchel, Christian ^a   Reinke, Britta ^a   Karakaya, Tarik ^a   Fußer, Fabian ^a   Pantel, Johannes ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Apolipoprotein4; DTI; FMRI; Memory; VBM

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; ALLELE; APOE4 GENE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; EPISODIC MEMORY; EVENT RELATED POTENTIAL; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; MENTAL TEST; NERVE CELL NETWORK; NEUROANATOMY; NEUROMODULATION; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RECALL; STRUCTURE ANALYSIS; VOXEL BASED MORPHOMETRY; YOUNG ADULT; BRAIN; ELECTROENCEPHALOGRAM; FEMALE; GENE; MALE; NERVE DEGENERATION; NEUROIMAGING; TASK PERFORMANCE;

APOLIPOPROTEIN4; DTI; FMRI; MEMORY; VBM;

ADULT; APOLIPOPROTEIN E4; BRAIN; BRAIN MAPPING; DIFFUSION TENSOR IMAGING; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, EPISODIC; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 84892855003     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.11.042     Document Type: Article

References (84)

1. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. NeuroImage 2000, 11:805-821.
2. Baxter L.C., Caselli R.J., Johnson S.C., Reiman E., Osborne D. Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol. Aging 2003, 24:947-952.
3. Beck A.T., Steer R.A., Brown G.K. Beck Depression Inventory. Manual 1996, The Psychological Corporation, San Antonio. 2nd edn.
4. Benedict R. Brief Visuospatial Memory Test-Revised Professional Manual 1997, Psychological Assessment Resources, Inc., Odessa, Fl.
5. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 2008, 9:768-778.
6. Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005, 64:501-508.
7. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 2000, 343:450-456.
8. *4 carriers. Neurobiol. Aging 2008, 29:981-991.
9. Bosch B., Arenaza-Urquijo E.M., Rami L., Sala-Llonch R., Junque C., Sole-Padulles C., Pena-Gomez C., Bargallo N., Molinuevo J.L., Bartres-Faz D. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol. Aging 2012, 33:61-74.
10. Braak H., Del Tredici K. Where, when, and in what form does sporadic Alzheimer's disease begin?. Curr. Opin. Neurol. 2012, 25:708-714.
11. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 2009, 10:333-344.
12. Bunce D., Anstey K.J., Burns R., Christensen H., Easteal S. Does possession of apolipoprotein E varepsilon4 benefit cognitive function in healthy young adults?. Neuropsychologia 2011, 49:1693-1697.
13. Caselli R.J., Reiman E.M. Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention. J. Alzheimers Dis. 2012, S405-S416.
14. Caselli R.J., Reiman E.M., Osborne D., Hentz J.G., Baxter L.C., Hernandez J.L., Alexander G.G. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 2004, 62:1990-1995.
15. Caselli R.J., Reiman E.M., Locke D.E., Hutton M.L., Hentz J.G., Hoffman-Snyder C., Woodruff B.K., Alexander G.E., Osborne D. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch. Neurol. 2007, 64:1306-1311.
16. Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L., Baxter L.C., Rapcsak S.Z., Shi J., Woodruff B.K., Locke D.E., Snyder C.H., Alexander G.E., Rademakers R., Reiman E.M. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N. Engl. J. Med. 2009, 361:255-263.
17. Clare L., Wilson B.A., Carter G., Roth I., Hodges J.R. Relearning face-name associations in early Alzheimer's disease. Neuropsychology 2002, 16:538-547.
18. Corder E.H., Ghebremedhin E., Taylor M.G., Thal D.R., Ohm T.G., Braak H. The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann. N. Y. Acad. Sci. 2004, 1019:24-28.
19. Damoiseaux J.S., Seeley W.W., Zhou J., Shirer W.R., Coppola G., Karydas A., Rosen H.J., Miller B.L., Kramer J.H., Greicius M.D. Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J. Neurosci. 2012, 32:8254-8262.
20. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. The California Verbal Learning Test 1987, Psychological Corporation, San Antonio, TX.
21. Deichmann R., Schwarzbauer C., Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. [Comparative Study Research Support, Non-U.S. Gov't]. NeuroImage 2004, 21(2):757-767.
22. Dennis N.A., Browndyke J.N., Stokes J., Need A., Burke J.R., Welsh-Bohmer K.A., Cabeza R. Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement. 2010, 6:303-311.
23. Dowell N.G., Ruest T., Evans S.L., King S.L., Tabet N., Tofts P.S., Rusted J.M. MRI of carriers of the apolipoprotein E e4 allele-evidence for structural differences in normal-appearing brain tissue in e4+ relative to e4- young adults. NMR Biomed. 2013, 26:674-682.
24. Evans S., Gray M.A., Dowell N.G., Tabet N., Tofts P.S., King S.L., Rusted J.M. APOE E4 carriers show prospective memory enhancement under nicotine, and evidence for specialisation within medial BA10. Neuropsychopharmacology 2013, 38:655-663.
25. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 1987, 149:351-356.
26. Filbey F.M., Slack K.J., Sunderland T.P., Cohen R.M. Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport 2006, 17:1585-1590.
27. Filippini N., MacIntosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., Matthews P.M., Beckmann C.F., Mackay C.E. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7209-7214.
28. Filippini N., Ebmeier K.P., MacIntosh B.J., Trachtenberg A.J., Frisoni G.B., Wilcock G.K., Beckmann C.F., Smith S.M., Matthews P.M., Mackay C.E. Differential effects of the APOE genotype on brain function across the lifespan. NeuroImage 2011, 54:602-610.
29. Fleisher A.S., Houston W.S., Eyler L.T., Frye S., Jenkins C., Thal L.J., Bondi M.W. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch. Neurol. 2005, 62:1881-1888.
30. Fleisher A.S., Sherzai A., Taylor C., Langbaum J.B., Chen K., Buxton R.B. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. NeuroImage 2009, 47:1678-1690.
31. Goebel R., Esposito F., Formisano E. Analysis of functional image analysis contest (FIAC) data with brainvoyager QX: From single-subject to cortically aligned group general linear model analysis and self-organizing group independent component analysis. Hum. Brain Mapp. 2006, 27:392-401.
32. Gold J.M., Carpenter C., Randolph C., Goldberg T.E., Weinberger D.R. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch. Gen. Psychiatry 1997, 54:159-165.
33. Griswold M.A., Jakob P.M., Heidemann R.M., Nittka M., Jellus V., Wang J., Kiefer B., Haase A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn. Reson. Med. 2002, 47:1202-1210.
34. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 2007, 8:101-112.
35. Hautzinger M., Keller F., Kühner C. BDI II Beck Depressions-Inventar Revision 2006, Harcourt Test Services, Frankfurt a.M.
36. Heise V., Filippini N., Ebmeier K.P., Mackay C.E. The APOE varepsilon4 allele modulates brain white matter integrity in healthy adults. [Comparative Study Research Support, Non-U.S. Gov't]. Mol. Psychiatry 2011, 16:908-916.
37. Holmes A.P., Blair R.C., Watson J.D., Ford I. Nonparametric analysis of statistic images from functional mapping experiments. J. Cereb. Blood Flow Metab. 1996, 16:7-22.
38. Ihle A., Bunce D., Kliegel M. APOE epsilon4 and cognitive function in early life: a meta-analysis. Neuropsychology 2012, 26:267-277.
39. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
40. Jenkinson M., Beckmann C.F., Behrens T.E., Woolrich M.W., Smith S.M. Fsl. NeuroImage 2012, 62:782-790.
41. Jorm A.F., Mather K.A., Butterworth P., Anstey K.J., Christensen H., Easteal S. APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology 2007, 21:1-8.
42. Kantarci K., Lowe V., Przybelski S.A., Weigand S.D., Senjem M.L., Ivnik R.J., Preboske G.M., Roberts R., Geda Y.E., Boeve B.F., Knopman D.S., Petersen R.C., Jack C.R. APOE modifies the association between Abeta load and cognition in cognitively normal older adults. Neurology 2012, 78:232-240.
43. Kim J., Basak J.M., Holtzman D.M. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009, 63:287-303.
44. Kukolja J., Thiel C.M., Eggermann T., Zerres K., Fink G.R. Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Neuroscience 2010, 168:487-497.
45. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest MWT-B 2005, Spitta Verlag, Balingen.
46. Lind J., Persson J., Ingvar M., Larsson A., Cruts M., Van Broeckhoven C., Adolfsson R., Backman L., Nilsson L.G., Petersson K.M., Nyberg L. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain 2006, 129:1240-1248.
47. Marchant N.L., King S.L., Tabet N., Rusted J.M. Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacology 2010, 35:1090-1096.
48. Martinez A.M., Benavente R. The AR face database. CVC Technical Report 1998.
49. McKiernan K.A., Kaufman J.N., Kucera-Thompson J., Binder J.R. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J. Cogn. Neurosci. 2003, 15:394-408.
50. Mondadori C.R., de Quervain D.J., Buchmann A., Mustovic H., Wollmer M.A., Schmidt C.F., Boesiger P., Hock C., Nitsch R.M., Papassotiropoulos A., Henke K. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb. Cortex 2007, 17:1934-1947.
51. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15:1-25.
52. Niemann H., Sturm W., Thöne-Otto A.I.T., Willmes K. California Verbal Learning Test. Deutsche Adaptation 2008, Pearson Assessment & Information GmbH, Frankfurt am Main.
53. Nyberg L., McIntosh A.R., Tulving E. Functional brain imaging of episodic and semantic memory with positron emission tomography. J. Mol. Med. 1998, 76:48-53.
54. O'Dwyer L., Lamberton F., Matura S., Scheibe M., Miller J., Rujescu D., Prvulovic D., Hampel H. White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines. PLoS One 2012, 7:e36024.
55. O'Dwyer L., Lamberton F., Matura S., Tanner C., Scheibe M., Miller J., Rujescu D., Prvulovic D., Hampel H. Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. PLoS One 2012, 7:e48895.
56. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
57. Palop J.J., Chin J., Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature 2006, 443:768-773.
58. Palop J.J., Mucke L., Roberson E.D. Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling. Methods Mol. Biol. 2011, 670:245-262.
59. Persson J., Lind J., Larsson A., Ingvar M., Sleegers K., Van Broeckhoven C., Adolfsson R., Nilsson L.G., Nyberg L. Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia 2008, 46:1679-1687.
60. *4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch. Neurol. 2006, 63:936-939.
61. Pihlajamaki M., O'Keefe K., Bertram L., Tanzi R.E., Dickerson B.C., Blacker D., Albert M.S., Sperling R.A. Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2010, 24:28-36.
62. Puttonen S., Elovainio M., Kivimaki M., Lehtimaki T., Keltikangas-Jarvinen L. The combined effects of apolipoprotein E polymorphism and low-density lipoprotein cholesterol on cognitive performance in young adults. Neuropsychobiology 2003, 48:35-40.
63. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
64. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 1996, 334:752-758.
65. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:284-289.
66. Reiman E.M., Chen K., Liu X., Bandy D., Yu M., Lee W., Ayutyanont N., Keppler J., Reeder S.A., Langbaum J.B., Alexander G.E., Klunk W.E., Mathis C.A., Price J.C., Aizenstein H.J., DeKosky S.T., Caselli R.J. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6820-6825.
67. Rentz D.M., Amariglio R.E., Becker J.A., Frey M., Olson L.E., Frishe K., Carmasin J., Maye J.E., Johnson K.A., Sperling R.A. Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia 2011, 49:2776-2783.
68. Rusted J.M., Evans S.L., King S.L., Dowell N., Tabet N., Tofts P.S. APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures. NeuroImage 2013, 65:364-373.
69. Schultz M.R., Lyons M.J., Franz C.E., Grant M.D., Boake C., Jacobson K.C., Xian H., Schellenberg G.D., Eisen S.A., Kremen W.S. Apolipoprotein E genotype and memory in the sixth decade of life. Neurology 2008, 70:1771-1777.
70. Shaw P., Lerch J.P., Pruessner J.C., Taylor K.N., Rose A.B., Greenstein D., Clasen L., Evans A., Rapoport J.L., Giedd J.N. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol. 2007, 6:494-500.
71. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6037-6042.
72. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
73. Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009, 44:83-98.
74. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., Behrens T.E. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 2006, 31:1487-1505.
75. Spaniol J., Davidson P.S., Kim A.S., Han H., Moscovitch M., Grady C.L. Event-related fMRI studies of episodic encoding and retrieval: meta-analyses using activation likelihood estimation. Neuropsychologia 2009, 47:1765-1779.
76. Sperling R.A., Bates J.F., Cocchiarella A.J., Schacter D.L., Rosen B.R., Albert M.S. Encoding novel face-name associations: a functional MRI study. Hum. Brain Mapp. 2001, 14:129-139.
77. Spreen O., Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary 1998, Oxford University Press, New York.
78. Trachtenberg A.J., Filippini N., Mackay C.E. The effects of APOE-epsilon4 on the BOLD response. Neurobiol. Aging 2012, 33:323-334.
79. Wechsler D. Wechsler Memory Scale. Manual 1997, The Psychological Corporation, San Antonio, TX. Third edition.
80. Werheid K., Clare L. Are faces special in Alzheimer's disease? Cognitive conceptualisation, neural correlates, and diagnostic relevance of impaired memory for faces and names. Cortex 2007, 43:898-906.
81. Whitwell J.L. Voxel-based morphometry: an automated technique for assessing structural changes in the brain. J. Neurosci. 2009, 29:9661-9664.
82. Wisdom N.M., Callahan J.L., Hawkins K.A. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol. Aging 2011, 32:63-74.
83. Wishart H.A., Saykin A.J., McAllister T.W., Rabin L.A., McDonald B.C., Flashman L.A., Roth R.M., Mamourian A.C., Tsongalis G.J., Rhodes C.H. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006, 67:1221-1224.
84. Xu G., McLaren D.G., Ries M.L., Fitzgerald M.E., Bendlin B.B., Rowley H.A., Sager M.A., Atwood C., Asthana S., Johnson S.C. The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain 2009, 132:383-391.